For decades, researchers fixated on the extraordinary potential nestled within the human immune system, particularly the formidable prowess of antibodies to combat cancer. Since monoclonal antibodies ...

The global cancer monoclonal antibodies (mAbs) market has witnessed remarkable growth, driven by advances in biotechnology, rising cancer prevalence, and the increasing demand for targeted therapies.

Three monoclonal antibodies (cetuximab, bevacizumab and panitumumab) have been approved for the treatment of colorectal cancer in the USA and a large number of other monoclonal antibodies are ...

Bispecific antibodies, which bind simultaneously to two different antigens, can attack tumors via novel mechanisms of action that cannot be evoked with combinations of conventional monoclonal ...

Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments for diseases such as cancer, Alzheimer's disease, autoimmune disorders ...